Role of inflammation in oral carcinogenesis (Part I): Histological grading of malignancy using a binary system

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1225-1231

  Piva, Marta Rabello ^a   de Souza, Lélia Batista ^b   Martins Filho, Paulo Ricardo Saquete ^a   Soares, Rosilene Calazans ^a   Santos, Thiago de Santana ^c   Andrade, Emanuel Sávio de Souza ^c  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Carcinoma; Cytokines; Immunohistochemistry; Inflammation

Indexed keywords

CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; EPITHELIUM DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; MOUTH INFLAMMATION; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 80052783104     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.382     Document Type: Article

References (27)

1. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y et al: The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 34: 329-333, 2005.
2. Broders AC: Squamous-cell epithelioma of the lip: a study of five hundred and thirty-seven cases. J Am Med Assoc 6: 656-664, 1920.
3. Broders AC: The microscopic grading of cancer. Surg Clin North Am 21: 947-961, 1941.
4. Wahi PM: Tipos histológicos de tumores orales y orofaringeos. Ginebra: Organización Mundial de la Salud, 1971.
5. Jakobsson PA, Eneroth GM, Killander D, Moberger G and Artenson B: Histologic classification and grading of malignancy in carcinoma of the larynx (a pilot study). Acta Radiol Ther Phys Biol 12: 1-8, 1973.
6. Crissman JD, Liu WY, Gluckman JL and Cummings G: Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 54: 2995-3001, 1984.
7. Anneroth G, Batsakis JG and Luna M: Review of the literature and a recommended system of malignancy grading of squamous cell carcinoma. Scand J Dent Res 95: 222-249, 1987.
8. Bryne M: Is the invasive front of an oral carcinoma the most important area for prognostication? Oral diseases 4: 70-77, 1998.
9. Costa Ade L, Araújo Júnior RF and Ramos CC: Correlation between TNM classification and malignancy histological feature of oral squamous cell carcinoma. Braz J Otorhinolaryngol 71: 181-187, 2005.
10. Da Silveira EJ, Miguel MC, Lima KC, Freitas Rde A, de Morais Mde L and Queiroz LM: Analysis of local immunity in squamous cell carcinoma of the tongue and lower lip. Exp Mol Pathol 88: 171-175, 2010.
11. Sabel MS, Hess SD, Egilmez NK, Conway TF Jr, Chen FA and Bankert RB: CTLA-4 blockade augments human Tlymphocyte-mediated suppression of lung tumor xenografts in SCID mice. Cancer Immunol Immunother 54: 944-952, 2005.
12. Chang MC, Chiang CP, Lin CL, Lee JJ, Hahn LJ and Jeng JH: Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol 41: 757-775, 2005.
13. Curiel TJ, Coukos G, Zou L et al: Specific recruitment of regulatory Tcells in ovarian carcinoma fosters immune privilege and predicts survival. Nat Med 10: 942-949, 2004.
14. +/regulatory Tcell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102: 18538-18543, 2005.
15. + regulatory Tcells. Nat Immunol 4: 330-336, 2003.
16. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG and Rudensky AY: Regulatory Tcell lineage specification by the forkhead transcription factor Fox P3. Immunity 22: 329-341, 2005.
17. Weitzman SA and Gordon LI: Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 76: 655-663, 1990.
18. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? The Lancet 85: 473-483, 2001.
19. Coussens LM and Werb Z: Inflammatory cells and cancer think different! J Exp Med 193: 23-26, 2001.
20. O'Byrne KJ and Dalgleish AG: Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85: 473-483, 2001.
21. Yan L, Zucker S and Toole BP: Roles of the multifunctional glycoprotein, emmprin (basigin; CD 147), in tumour progression. Thromb Haemost 93: 199-204, 2005.
22. Mignona MD, Fedele S, Lo Russo L, Lo Muzio L and Bucci E: Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 40: 120-130, 2004.
23. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK and Sethi G: Inflammation and cancer: How hot is the link? Biochem Pharmacol 72: 1605-1621, 2006.
24. Vigneswaran N, Beckers S and Waigel S: Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp Mol Pathol 80: 147-159, 2006.
25. Warnakulasuriya S, Reibel J, Bouquot J and Dabelsteen E: Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37: 127-133, 2008.
26. Abbas NF, Labib El-Sharkawy S, Abbas EA and Abdel Monem El-Shaer M: Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radio Oral Endod 103: 385-390, 2007.
27. Hoffmann TK, Bier H and Whiteside TL: Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53: 1055-1067, 2004.